Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanofi Pasteur Shenzhen TIV vs Hualan TIV in Adults 18–59
CTR20171536Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2018
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent influenza vaccine in influenza, sponsored by Sanofi. Started Jan 2018; status: completed.
02
Drugs
trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20171536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171536.